Exacerbation of Activated Latent Tuberculosis Following COVID-19: A Case Report
Lautika Sonkar, Rampal Singh, Jagdamba Sharan, Deepika Verma
Journal of Medical Microbiology and Infectious Diseases · 2022-12
Abstract
While the COVID-19 pandemic affects millions, other infectious diseases might be overlooked. One of these crucial diseases is tuberculosis (TB), a highly infectious bacterial respiratory disease. According to WHO, TB is among the top 10 causes of death globally, with about one-quarter of the world's population infected. COVID-19 has emerged as a potential risk factor for TB in highly prevalent countries because of immunosuppression. This case report highlights a female patient who presented with swelling over the left supraclavicular region, which was very slow in progression. Following COVID-19 infection, a significant increase in swelling within a short time occurred, which was associated with easy fatigability, loss of appetite, generalized weakness, and significant weight loss. Based on investigations, a TB diagnosis was made. Few studies are available regarding the exacerbation of activated latent tuberculosis following COVID-19. Hence, this case report could help in screening and managing such cases.
MeSH terms
- Coronavirus disease 2019 (COVID-19)
- Exacerbation
- Latent tuberculosis
- Tuberculosis
- Medicine
- 2019-20 coronavirus outbreak
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Virology
- Intensive care medicine
- Immunology